Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR3E | A5X5Y0 | 3/20 | 1.00 |
| ▸ | HTR3B | O95264 | 3/20 | 1.00 |
| ▸ | HTR3A | P46098 | 3/20 | 1.00 |
| ▸ | HTR3D | Q70Z44 | 3/20 | 1.00 |
| ▸ | HTR3C | Q8WXA8 | 3/20 | 1.00 |
| ▸ | CHRNA7 | P36544 | 3/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.72 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.72 |
| ▸ | LMNA | P02545 | 1/20 | 0.72 |
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.67 |
| ▸ | GMNN | O75496 | 1/20 | 0.65 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.65 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | MTOR | P42345 | 1/20 | 0.65 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.65 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzoyl Tropine SCHEMBL30954638 | 1.00 | HTR3E (1.00) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| Benzoyl Tropine SCHEMBL1103723 | 1.00 | HTR3E (1.00) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| Benzoyl Tropine SCHEMBL3498565 | 0.98 | HTR3E (0.97) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL6500334 | 0.86 | HTR3E (0.76) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL6500328 | 0.86 | HTR3E (0.76) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL7652481 | 0.86 | HTR3A (0.75) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL7652475 | 0.86 | HTR3A (0.75) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL1851573 | 0.85 | HTR3E (0.74) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL6504512 | 0.85 | CYP2D6 (0.97) | HTR3EHTR3BHTR3AHTR3DHTR3C | |
| SCHEMBL1851576 | 0.85 | HTR3E (0.74) | HTR3EHTR3BHTR3AHTR3DHTR3C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 260 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250319025-A9 | COMPOSITIONS COMPRISING MODIFIED PHOSPHOLIPIDS AND USES THEREOF | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2025-10-16 | — | — | US | claimed |
| US-12419619-B2 | Aspiration device | YALE UNIVERSITY (US) | 2025-09-23 | — | — | US | claimed |
| US-20250205278-A1 | METHODS AND COMPOSITIONS FOR WOUND HEALING | ABBOTT NICHOLAS L (US) | 2025-06-26 | — | — | US | claimed |
| WO-2025128639-A1 | HYDROGELS COMPRISING PROTEIN-STABILIZED NANOPARTICLES FOR EXTENDED RELEASE | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2025-06-19 | — | — | WO | claimed |
| WO-2025075976-A2 | METHYL-BRANCHED LIPOSOMES FOR SUSTAINED DRUG DELIVERY | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2025-04-10 | — | — | WO | claimed |
| WO-2025059510-A1 | COCA LEAF EXTRACT FOR NEUROPSYCHIATRIC DISORDERS | MAGDALENA BIOSCIENCES, INC. (US) | 2025-03-20 | — | — | WO | claimed |
| US-20250049711-A1 | COMPOSITIONS COMPRISING MODIFIED PHOSPHOLIPIDS AND USES THEREOF | THE CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2025-02-13 | — | — | US | claimed |
| US-12168026-B2 | Methods and compositions for wound healing | ABBOTT NICHOLAS L (US) | 2024-12-17 | — | — | US | claimed |
| EP-4444274-A1 | COMPOSITIONS COMPRISING MODIFIED PHOSPHOLIPIDS AND USES THEREOF | The Children's Medical Center Corporation (US) | 2024-10-16 | — | — | EP | claimed |
| US-20240139237-A1 | METHODS AND COMPOSITIONS FOR WOUND HEALING | ABBOTT NICHOLAS L (US) | 2024-05-02 | — | — | US | claimed |
| EP-2001877-A1 | METHOD FOR EXTRACTING TARGET ALKALOID USING AN IONIC LIQUID AS EXTRACTING SOLVENT | Bioniqs Limited (GB) | 2008-12-17 | — | — | EP | claimed |
| EP-1931416-A2 | IONTOPHORESIS METHOD AND APPARATUS FOR SYSTEMIC DELIVERY OF ACTIVE AGENTS | TTI ELLEBEAU, INC. (JP) | 2008-06-18 | — | — | EP | claimed |
| WO-2007110637-A1 | METHOD FOR EXTRACTING TARGET ALKALOID USING AN IONIC LIQUID AS EXTRACTING SOLVENT | BIONIQS LIMITED (GB) | 2007-10-04 | — | — | WO | claimed |
| US-20070093788-A1 | Iontophoresis method and apparatus for systemic delivery of active agents | TRANSCUTANEOUS TECHNOLOGIES INC. (JP) | 2007-04-26 | — | — | US | claimed |
| WO-2007041300-A2 | IONTOPHORESIS METHOD AND APPARATUS FOR SYSTEMIC DELIVERY OF ACTIVE AGENTS | TTI ELLEBEAU, INC. (JP) | 2007-04-12 | — | — | WO | claimed |
| EP-0687172-B1 | SOLID LIPID PARTICLES, PARTICLES OF BIOACTIVE AGENTS AND METHODS FOR THE MANUFACTURE AND USE THEREOF | PHARMACIA AB (SE) | 2002-12-04 | — | — | EP | claimed |
| US-6207178-B1 | STABLE SUSPENSION | KABI PHARMACIA AB (SE) | 2001-03-27 | — | — | US | claimed |
| US-5785976-A | Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof | PHARMACIA & UPJOHN AB (SE) | 1998-07-28 | — | — | US | claimed |
| EP-0687172-A1 | SOLID LIPID PARTICLES, PARTICLES OF BIOACTIVE AGENTS AND METHODS FOR THE MANUFACTURE AND USE THEREOF | Pharmacia & Upjohn Aktiebolag (SE) | 1995-12-20 | — | — | EP | claimed |
| WO-1994020072-A1 | SOLID LIPID PARTICLES, PARTICLES OF BIOACTIVE AGENTS AND METHODS FOR THE MANUFACTURE AND USE THEREOF | PHARMACIA AB (SE) | 1994-09-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250049711-A1 | COMPOSITIONS COMPRISING MODIFIED PHOSPHOLIPIDS AND USES THEREOF | PHOSPHO1, SGMS1, LIPA | HTR3E 2743/4885HTR3B 3036/4885HTR3A 2857/4885 |
| US-20250319025-A9 | COMPOSITIONS COMPRISING MODIFIED PHOSPHOLIPIDS AND USES THEREOF | PHOSPHO1, SGMS1, LIPA | HTR3E 2743/4885HTR3B 3036/4885HTR3A 2857/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.